AKU
Akumin Inc. [AKU] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AKU Stock Summary
In the News
AKU Financial details
Company Rating
Neutral
Market Cap
26.27M
Income
-224.92M
Revenue
743.67M
Book val./share
-1.98
Cash/share
0.42
Dividend
-
Dividend %
-
Employees
1.74K
Optionable
No
Shortable
Yes
Earnings
08 Nov 2022
P/E
-0.12
Forward P/E
-
PEG
-0
P/S
0.04
P/B
-0.15
P/C
0.69
P/FCF
1.22
Quick Ratio
0.88
Current Ratio
0.99
Debt / Equity
-8.28
LT Debt / Equity
-8.04
-
-
EPS (TTM)
-2.65
EPS next Y
-
EPS next Q
-
EPS this Y
275.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
37.1%
Revenue Q/Q
-1.47%
EPS Q/Q
234.38%
-
-
-
-
SMA20
34.78%
SMA50
-
SMA100
-
Inst Own
1.78%
Inst Trans
0.45%
ROA
-14%
ROE
283%
ROC
-0.02%
Gross Margin
18%
Oper. Margin
-4%
Profit Margin
-30%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.118-1.9
52W High
-
52W Low
-
RSI
51.02
Rel Volume
0.03
Avg Volume
3.63M
Volume
102.26K
Perf Week
-9.38%
Perf Month
-
Perf Quarter
-
Perf Half Y
69.59%
-
-
-
-
Beta
0.451333
-
-
Volatility
0.02%, 0.06%
Prev Close
0%
Price
0.29
Change
-1.69%
AKU Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.66 | 3.72 | 3.58 | 5.48 | 8.38 | |
| Net income per share | 0.13 | 0.13 | -0.25 | -0.45 | -1.69 | |
| Operating cash flow per share | 0.11 | 0.3 | 0.38 | 0.22 | 0.73 | |
| Free cash flow per share | -0.06 | 0.11 | 0.19 | -0.01 | 0.23 | |
| Cash per share | 0.33 | 0.35 | 0.63 | 0.63 | 0.66 | |
| Book value per share | 1.79 | 2.08 | 1.91 | 1.37 | -0.54 | |
| Tangible book value per share | -0.48 | -3.16 | -3.25 | -12.15 | -11.4 | |
| Share holders equity per share | 1.79 | 2.08 | 1.91 | 1.37 | -0.54 | |
| Interest debt per share | 2.12 | 7.62 | 8.14 | 19.56 | 17.86 | |
| Market cap | 174.6M | 199.58M | 211.01M | 134.46M | 64.3M | |
| Enterprise value | 272.78M | 654.36M | 704.47M | 1.53B | 1.48B | |
| P/E ratio | 23.05 | 23.07 | -11.94 | -3.86 | -0.42 | |
| Price to sales ratio | 1.13 | 0.81 | 0.84 | 0.32 | 0.09 | |
| POCF ratio | 27.2 | 10.05 | 7.91 | 7.89 | 0.98 | |
| PFCF ratio | -52.58 | 26.93 | 15.9 | -164.58 | 3.12 | |
| P/B Ratio | 1.68 | 1.44 | 1.57 | 1.28 | -1.33 | |
| PTB ratio | 1.68 | 1.44 | 1.57 | 1.28 | -1.33 | |
| EV to sales | 1.76 | 2.64 | 2.8 | 3.62 | 1.98 | |
| Enterprise value over EBITDA | 10.74 | 8.84 | 14.36 | 25.48 | 10.61 | |
| EV to operating cash flow | 42.5 | 32.95 | 26.39 | 89.5 | 22.71 | |
| EV to free cash flow | -82.15 | 88.29 | 53.09 | -1.87K | 72.05 | |
| Earnings yield | 0.04 | 0.04 | -0.08 | -0.26 | -2.36 | |
| Free cash flow yield | -0.02 | 0.04 | 0.06 | -0.01 | 0.32 | |
| Debt to equity | 1.13 | 3.45 | 4.01 | 13.69 | -30.7 | |
| Debt to assets | 0.49 | 0.72 | 0.75 | 0.75 | 0.84 | |
| Net debt to EBITDA | 3.86 | 6.14 | 10.06 | 23.24 | 10.15 | |
| Current ratio | 2.44 | 2.27 | 2.69 | 1.13 | 1.14 | |
| Interest coverage | 2.6 | 1.58 | 1.06 | 0.21 | 0.35 | |
| Income quality | 0.85 | 2.3 | -1.51 | -0.49 | -0.43 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0.01 | 0.01 | 0.01 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.56 | 0.53 | 0.51 | 0.65 | 0.66 | |
| Capex to operating cash flow | -1.52 | -0.63 | -0.5 | -1.05 | -0.68 | |
| Capex to revenue | -0.06 | -0.05 | -0.05 | -0.04 | -0.06 | |
| Capex to depreciation | -0.99 | -0.44 | -0.66 | -0.4 | -0.46 | |
| Stock based compensation to revenue | 0.04 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham number | 2.29 | 2.47 | 3.29 | 3.74 | 4.53 | |
| ROIC | 0.09 | 0.05 | 0.03 | 0 | 0.03 | |
| Return on tangible assets | 0.07 | 0.03 | -0.05 | -0.05 | -0.25 | |
| Graham Net | -1.59 | -6.56 | -6.65 | -18.92 | -16.49 | |
| Working capital | 29.6M | 61.75M | 87.53M | 20.98M | 23.43M | |
| Tangible asset value | -27.8M | -210.01M | -227.62M | -933.35M | -1.02B | |
| Net current asset value | -84.19M | -411.6M | -439.49M | -1.41B | -1.43B | |
| Invested capital | 1.13 | 3.45 | 4.01 | 13.69 | -30.7 | |
| Average receivables | 21.39M | 56.34M | 87M | 106.33M | 117.85M | |
| Average payables | 12.42M | 18.3M | 21.05M | 27.36M | 35.47M | |
| Average inventory | 0 | 0 | 0 | 4.1M | 8.1M | |
| Days sales outstanding | 70.3 | 122.24 | 132.37 | 105.34 | 55.59 | |
| Days payables outstanding | 45.15 | 46.64 | 37.65 | 34.83 | 21.97 | |
| Days of inventory on hand | 0 | 0 | 0 | 8.32 | 4.8 | |
| Receivables turnover | 5.19 | 2.99 | 2.76 | 3.46 | 6.57 | |
| Payables turnover | 8.09 | 7.83 | 9.7 | 10.48 | 16.61 | |
| Inventory turnover | 0 | 0 | 0 | 43.89 | 76.02 | |
| ROE | 0.07 | 0.06 | -0.13 | -0.33 | 3.14 | |
| Capex per share | -0.17 | -0.19 | -0.19 | -0.23 | -0.5 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
| Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.15 | 2.08 | 2.63 | 2.09 | 2.04 | |
| Net income per share | -0.29 | -0.56 | -0.7 | -0.32 | -1.07 | |
| Operating cash flow per share | 0.13 | 0.39 | 0.13 | 0.04 | 0.16 | |
| Free cash flow per share | 0.07 | 0.2 | -0.04 | 0.01 | 0.06 | |
| Cash per share | 0.43 | 0.66 | 0.85 | 0.51 | 0.42 | |
| Book value per share | 0.51 | -0.08 | -0.69 | -0.92 | -1.98 | |
| Tangible book value per share | -11.04 | -11.12 | -14.55 | -11.72 | -11.99 | |
| Share holders equity per share | 0.51 | -0.08 | -0.69 | -0.92 | -1.98 | |
| Interest debt per share | 16.5 | 16.7 | 21.54 | 16.81 | 16.74 | |
| Market cap | 53.67M | 153.11M | 50.39M | 61.08M | 16.29M | |
| Enterprise value | 1.46B | 1.56B | 1.47B | 1.49B | 1.46B | |
| P/E ratio | -0.51 | -0.77 | -0.26 | -0.52 | -0.04 | |
| Price to sales ratio | 0.28 | 0.82 | 0.27 | 0.33 | 0.09 | |
| POCF ratio | 4.56 | 4.39 | 5.34 | 18.49 | 1.11 | |
| PFCF ratio | 8.69 | 8.72 | -19.64 | 76.73 | 2.86 | |
| P/B Ratio | 1.17 | -20.37 | -1.05 | -0.74 | -0.09 | |
| PTB ratio | 1.17 | -20.37 | -1.05 | -0.74 | -0.09 | |
| EV to sales | 7.62 | 8.36 | 7.96 | 7.97 | 7.91 | |
| Enterprise value over EBITDA | 39.57 | 43.08 | 41.15 | 49.11 | 58.49 | |
| EV to operating cash flow | 124.42 | 44.74 | 155.93 | 452.45 | 99.8 | |
| EV to free cash flow | 237.06 | 88.81 | -573.1 | 1.88K | 256.57 | |
| Earnings yield | -0.49 | -0.32 | -0.98 | -0.48 | -5.93 | |
| Free cash flow yield | 0.12 | 0.11 | -0.05 | 0.01 | 0.35 | |
| Debt to equity | 31.63 | -194.95 | -30.7 | -17.83 | -8.28 | |
| Debt to assets | 0.78 | 0.81 | 0.84 | 0.86 | 0.91 | |
| Net debt to EBITDA | 38.12 | 38.85 | 39.74 | 47.1 | 57.84 | |
| Current ratio | 1.08 | 1.13 | 1.14 | 1.09 | 0.99 | |
| Interest coverage | 0.4 | 0.37 | 0.41 | 0.24 | -2.07 | |
| Income quality | -0.45 | -0.7 | -0.19 | -0.11 | -0.15 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.67 | 0.66 | 0.66 | 0.67 | 0.66 | |
| Capex to operating cash flow | -0.48 | -0.5 | -1.27 | -0.76 | -0.61 | |
| Capex to revenue | -0.03 | -0.09 | -0.06 | -0.01 | -0.05 | |
| Capex to depreciation | -0.22 | -0.69 | -0.52 | -0.11 | -0.26 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.83 | 1.02 | 3.3 | 2.6 | 6.9 | |
| ROIC | 0.01 | 0.01 | 0.01 | 0 | -0.04 | |
| Return on tangible assets | -0.04 | -0.08 | -0.08 | -0.05 | -0.18 | |
| Graham Net | -16.39 | -16.36 | -21.04 | -16.51 | -16.64 | |
| Working capital | 13.71M | 22.03M | 23.43M | 14.15M | -2.23M | |
| Tangible asset value | -988.23M | -995.85M | -1.02B | -1.05B | -1.09B | |
| Net current asset value | -1.42B | -1.42B | -1.43B | -1.44B | -1.46B | |
| Invested capital | 31.63 | -194.95 | -30.7 | -17.83 | -8.28 | |
| Average receivables | 126.31M | 119.26M | 113.27M | 114.43M | 115.24M | |
| Average payables | 33.95M | 30.74M | 32.16M | 31.04M | 34.52M | |
| Average inventory | 8.9M | 8.91M | 8.22M | 8.16M | 8.4M | |
| Days sales outstanding | 59.09 | 54.2 | 55.65 | 55.03 | 56.38 | |
| Days payables outstanding | 19.67 | 16.54 | 22.27 | 14.73 | 24.74 | |
| Days of inventory on hand | 5.46 | 5.04 | 4.87 | 4.82 | 4.81 | |
| Receivables turnover | 1.52 | 1.66 | 1.62 | 1.64 | 1.6 | |
| Payables turnover | 4.57 | 5.44 | 4.04 | 6.11 | 3.64 | |
| Inventory turnover | 16.47 | 17.85 | 18.49 | 18.69 | 18.7 | |
| ROE | -0.57 | 6.62 | 1.02 | 0.35 | 0.54 | |
| Capex per share | -0.06 | -0.19 | -0.17 | -0.03 | -0.1 |
AKU Frequently Asked Questions
What is Akumin Inc. stock symbol ?
Akumin Inc. is a US stock , located in Plantation of Fl and trading under the symbol AKU
What is Akumin Inc. stock quote today ?
Akumin Inc. stock price is $0.29 today.
Is Akumin Inc. stock public?
Yes, Akumin Inc. is a publicly traded company.
Company Profile
- Volume Average 3.63M
- Market Capitalization 26.27M
- Employee 1.74K
- CEO Mr. Riadh Zine-El-Abidine
- Headquarters Plantation,FL,US
- IPO Date 2020-09-03
-
Website
https://www.akumin.com 
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
